Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,241
Closed -$1.01M 51
2025
Q1
$1.01M Buy
+3,241
New +$957K 0.52% 32
2023
Q1
Sell
-115
Closed -$30.2K 40
2022
Q4
$30.2K Buy
115
+5
+5% +$1.34K 0.01% 64
2022
Q3
$25K Sell
110
-80
-42% -$19.4K 0.01% 48
2022
Q2
$47K Buy
190
+71
+60% +$17.4K 0.09% 43
2022
Q1
$29K Buy
+119
New +$27.3K 0.01% 93

Other funds holding AMGN

Win Advisors's AMGN Position: Q2 2025 in Review

Win Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 3,241 shares — an estimated $1.01M sold.

Win Advisors first reported a position in AMGN in Q1 2022 and held it in 5 quarters. The position peaked at $1.01M in Q1 2025. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Win Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Win Advisors sold 3,241 Amgen shares in Q2 2025, an estimated $1.01M.
  • Win Advisors first reported a position in Amgen in Q1 2022 and held it in 5 quarters.
  • Win Advisors's Amgen position peaked at $1.01M in Q1 2025.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Win Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.